Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $13.11 million. The enterprise value is -$29.43 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SNSE has 25.15 million shares outstanding. The number of shares has decreased by -14.70% in one year.
Current Share Class | 25.15M |
Shares Outstanding | 25.15M |
Shares Change (YoY) | -14.70% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 2.10% |
Owned by Institutions (%) | 8.85% |
Float | 16.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.29 |
P/TBV Ratio | 0.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.84, with a Debt / Equity ratio of 0.10.
Current Ratio | 8.84 |
Quick Ratio | 8.64 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -313.29 |
Financial Efficiency
Return on equity (ROE) is -51.04% and return on invested capital (ROIC) is -31.81%.
Return on Equity (ROE) | -51.04% |
Return on Assets (ROA) | -30.19% |
Return on Capital (ROIC) | -31.81% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.06M |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.02% in the last 52 weeks. The beta is 0.06, so SNSE's price volatility has been lower than the market average.
Beta (5Y) | 0.06 |
52-Week Price Change | -21.02% |
50-Day Moving Average | 0.52 |
200-Day Moving Average | 0.78 |
Relative Strength Index (RSI) | 50.65 |
Average Volume (20 Days) | 397,340 |
Short Selling Information
The latest short interest is 194,685, so 0.77% of the outstanding shares have been sold short.
Short Interest | 194,685 |
Short Previous Month | 223,158 |
Short % of Shares Out | 0.77% |
Short % of Float | 1.18% |
Short Ratio (days to cover) | 0.29 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -32.58M |
Pretax Income | -29.67M |
Net Income | -29.80M |
EBITDA | -31.26M |
EBIT | -32.58M |
Earnings Per Share (EPS) | -$1.19 |
Full Income Statement Balance Sheet
The company has $47.00 million in cash and $4.47 million in debt, giving a net cash position of $42.53 million or $1.69 per share.
Cash & Cash Equivalents | 47.00M |
Total Debt | 4.47M |
Net Cash | 42.53M |
Net Cash Per Share | $1.69 |
Equity (Book Value) | 45.78M |
Book Value Per Share | 1.82 |
Working Capital | 42.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$25.04 million and capital expenditures -$146,000, giving a free cash flow of -$25.19 million.
Operating Cash Flow | -25.04M |
Capital Expenditures | -146,000 |
Free Cash Flow | -25.19M |
FCF Per Share | -$1.00 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |